Prestige Consumer Healthcare Inc. (PBH): Net Income
$190.30M
Year ended 2026-03-31
$172.01M
Trailing 12 months to 2026-06-30
+2.9%
5-year compound annual growth
+6.7%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $190.30M | -11.3% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $214.60M | +2.5% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $209.34M | n/m | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | -$82.31M | n/m | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $205.38M | +24.7% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $164.68M | +15.7% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $142.28M | n/m | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | -$35.80M | n/m | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $339.57M | +389.3% | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $69.39M | -30.5% | 2019-05-13, From 2016-04-01 |
| 2016-03-31 | $99.91M | +27.7% | 2018-05-10, From 2015-04-01 |
| 2015-03-31 | $78.26M | +7.8% | 2017-05-17, From 2014-04-01 |
| 2014-03-31 | $72.61M | +10.9% | 2016-05-17, From 2013-04-01 |
| 2013-03-31 | $65.50M | +76.0% | 2015-05-14, From 2012-04-01 |
| 2012-03-31 | $37.21M | +27.4% | 2014-05-19, From 2011-04-01 |
| 2011-03-31 | $29.22M | -9.0% | 2013-05-17, From 2010-04-01 |
| 2010-03-31 | $32.12M | n/a | 2012-05-18, From 2009-04-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $190.30M | -11.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $391.00M | +72.7% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$288.28M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $210.00M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$381.39M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $78.34M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $158.69M | +9.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $30.11M | n/m |
| Alkermes plc. (ALKS) | 2025-12-31 | $241.66M | -34.2% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗